The latest medication guide for sotoraxib, what should you pay attention to when taking it?

Sotorasib is an anti-cancer drug used to treat KRAS G12C mutated non-small cell lung cancer (NSCLC).

1. Doctor’s guidance and monitoring:

Patients should receive detailed consultation and evaluation by a professional physician before using sotoraxib. Doctors consider a patient's medical history, disease characteristics, and overall health to determine the most appropriate medication regimen.

Patients need to be monitored by a doctor regularly during medication. This may include laboratory tests, imaging tests, etc. to evaluate the drug's efficacy and monitor potential side effects.

2. Dose and regimen:

The dosage is usually determined by the doctor based on the patient's specific condition. Patients should take their medications exactly as recommended by their doctor and should not change the dosage or stop taking the medication on their own.

In some cases, doctors may adjust the dose of a drug based on the patient's response and tolerance.

3. Side effects and adverse reactions:

Patients should be aware of possible side effects, such as fatigue, nausea, diarrhea, skin reactions, etc. These side effects usually occur early in the medication, but patients should report any discomfort to their doctor immediately.

The doctor may recommend some supportive care to relieve side effects or adjust the dose of the medication if necessary.

4. Medicine for special groups:

The use of sotoraxib may require more cautious consideration in elderly patients or in patients with impaired hepatic or renal function. Doctors will adjust treatment plans based on individual differences.

5. Diet and drug interactions during medication:

Some drugs may interact with sotoraxib, affecting drug absorption and metabolism. Patients should inform their doctors about all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements.

During medication, patients may need to pay attention to some dietary restrictions or recommendations to ensure the best effect of the medication.

6. Lifestyle and activities during treatment:

The doctor may make some suggestions about the patient's lifestyle and activities while taking the medication. This may include diet, exercise and general lifestyle habits.

7. Pregnant and lactating patients:

For pregnant or lactating patients, physicians need to consider the potential risks and benefits when deciding whether to continue using sotorasiib. This requires in-depth discussion and decision-making between patient and physician.

Patients should always follow their doctor's recommendations and pay close attention to their body's reactions when using sotorasiib. Because drug therapy is a dynamic process, medication guidelines may be updated based on new research and practical experience. Therefore, patients should maintain good communication with their doctors during medication and report any discomfort in a timely manner to ensure optimal treatment effects and minimal side effects. In addition, patients can always consult their doctor for the latest Medication Guide for more detailed and personalized information.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.